InGeneron pulls in $20 mln Series D
Houston, Texas and Germany-based InGeneron Inc, a regenerative medicine and cell therapy company, has raised $20 million in Series D funding. The investor was Sanford Health.
6 March 2017•1 min read
Houston, Texas and Germany-based InGeneron Inc, a regenerative medicine and cell therapy company, has raised $20 million in Series D funding. The investor was Sanford Health.
